Racial Heterogeneity in Treatment Effects in Peripheral Artery Disease: Insights From the CLEVER Trial (Claudication: Exercise Versus Endoluminal Revascularization).

Pubmed ID: 29643064

Pubmed Central ID: PMC5901766

Journal: Circulation. Cardiovascular quality and outcomes

Publication Date: April 1, 2018

MeSH Terms: Humans, Male, Female, United States, Middle Aged, Treatment Outcome, Quality of Life, Health Status Disparities, Time Factors, Peripheral Arterial Disease, Recovery of Function, Canada, Exercise Tolerance, Exercise Therapy, Surveys and Questionnaires, Walk Test, Endovascular Procedures, Intermittent Claudication, White People, Black or African American

Grants: T32 HL110837, U01 HL077221

Authors: Murphy TP, Spertus JA, Cohen D, Pokharel Y, Jones PG, Graham G, Collins T, Regensteiner JG, Smolderen K

Cite As: Pokharel Y, Jones PG, Graham G, Collins T, Regensteiner JG, Murphy TP, Cohen D, Spertus JA, Smolderen K. Racial Heterogeneity in Treatment Effects in Peripheral Artery Disease: Insights From the CLEVER Trial (Claudication: Exercise Versus Endoluminal Revascularization). Circ Cardiovasc Qual Outcomes 2018 Apr;11(4):e004157.

Studies:

Abstract